Complex Generics May Be Part Of White House Drug Pricing Response
Executive Summary
Document that appears to be fueling upcoming executive order includes ideas for relaxing FDA standards for complex generic approval, which may be one way of creating pressure to lower prices.
You may also be interested in...
Trump Administration's Pharma-Friendly Pricing Proposals Prompt Pushback
As work on policy development and executive orders continues, critics implore Trump to return to his "getting away with murder" roots.
Drug Pricing 'Deeper Dive' Planned By Senate Cmte. As Industry Avoids First Blood
Hearings in July and the fall will follow, but if the first session was any indication, industry doesn't have anything to worry about.
FDA User Fee Bill: House Cmte. Makes Technical Changes, Adds Pricing Resolution
House Energy and Commerce Committee refines FDA Reauthorization Act and adopts a ‘sense of Congress’ resolution on drug pricing, but largely steers clear of other potentially controversial add-ons that could bog down the measure.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Generics Bulletin?
Request a free trial today!
Register for our free email digests:
Register for our free email digests: